viernes, 13 de septiembre de 2024

FDA approves atezolizumab and hyaluronidase-tqjs for subcutaneous injection

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-atezolizumab-and-hyaluronidase-tqjs-subcutaneous-injection?utm_medium=email&utm_source=govdelivery

No hay comentarios: